Skip to content

Study for Equal-dose Ropivacaine Spinal Anesthesia Combined with Epidural Anesthesia for Cesarean Section

Study for Equal-dose Ropivacaine Spinal Anesthesia Combined with Epidural Anesthesia for Cesarean Section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030968
Enrollment
Unknown
Registered
2020-03-20
Start date
2020-03-20
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean section

Interventions

0.6%ropivacaine:0.75% ropivacaine 1.2ml withdraw cerebrospinal fluid to 1.5ml
0.5%ropivacaine:0.75% ropivacaine 1.2ml withdraw cerebrospinal fluid to 1.8ml
0.4%????:0.75% ropivacaine 1.2ml withdraw cerebrospinal fluid to 2.25ml

Sponsors

The Fourth Affliated Hospital Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Single-term and full-term pregnancy; (2) Weight 55-80 kg; (3) Height 155-165 cm; (4) American Society of Anesthesiologists (ASA) Grade I-II

Exclusion criteria

Exclusion criteria: (1) Those who are allergic to the research drug; (2) Those who are contraindicated in spinal canal puncture; (3) Those with pregnancy-induced hypertension, diabetes, heart disease; (4) Those with uterine fibroids, ovarian cysts, etc. that require surgical treatment; (5) Obstetric emergencies such as placental abruption, placenta previa, placenta implantation, etc.; (6) Switch to general anesthesia during surgery.

Design outcomes

Primary

MeasureTime frame
The rate of intraoperative phenylephrine usage/The rate of lidocaine usage;

Secondary

MeasureTime frame
Vital signs?block plane?block time and adverse reaction in different time points;

Countries

China

Contacts

Public ContactLi Xiuqin

The Fourth Affliated Hospital Zhejiang University School of Medicine

lovexq999@zju.edu.cn+86 13858112682

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026